RECAP study group, Tsukamoto S, Kobayashi K, et al
Comparing Ro vs Zealthy matters because GLP-1 therapy is not one-size-fits-all
Yes, the general principles of storage and handling apply to most research peptides, including Tirzepatide
If youre currently using a compounded GLP-1: Dont panic, but dont delay either Talk to your healthcare provider about transitioning to FDA-approved options If your current provider cant help, consider exploring telehealth services that offer weight loss support Check if your insurance covers FDA-approved GLP-1s (many do now) Look into manufacturer savings programs, which can significantly reduce costs Be prepared to start at a lower dose of the FDA-approved version and titrate up as directed Be proactive, Gardner advises
For Wegovy at the higher 2.4 mg weight management dose, the incidence jumps to approximately 7% of adults
While its efficacy profile is compelling, it remains an investigational compound requiring further long-term safety and regulatory evaluation before widespread clinical adoption